Fasinumab
R475-PN-1524
Phase 3 small_molecule completed
Quick answer
Fasinumab for Low Back Pain is a Phase 3 program (small_molecule) at Regeneron UK Limited with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Regeneron UK Limited
- Indication
- Low Back Pain
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed